BIO-TECHNE Corp vs DENTSPLY SIRONA Inc — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while DENTSPLY SIRONA Inc trades at $13.56 (market cap $2.70B). The key difference: BIO-TECHNE Corp is far larger — about 4.1× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals.
| TECH | XRAY | |
|---|---|---|
Market Cap | $11.16B | $2.70B |
Sector | Health | Health |
52-Week High | $72.12 | $16.85 |
52-Week Low | $43.31 | $9.64 |
Enterprise Value | $11.24B | $4.84B |
Dividend Yield | 0.45% | 5.04% |
Trailing returns across standard periods
Latest headlines on both assets
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →